PATANJALI - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.6
| Stock Code | PATANJALI | Market Cap | 49,721 Cr. | Current Price | 457 ₹ | High / Low | 654 ₹ |
| Stock P/E | 29.6 | Book Value | 111 ₹ | Dividend Yield | 0.77 % | ROCE | 15.6 % |
| ROE | 12.1 % | Face Value | 2.00 ₹ | DMA 50 | 482 ₹ | DMA 200 | 532 ₹ |
| Chg in FII Hold | -1.62 % | Chg in DII Hold | -0.98 % | PAT Qtr | 624 Cr. | PAT Prev Qtr | 517 Cr. |
| RSI | 40.4 | MACD | -5.97 | Volume | 19,06,145 | Avg Vol 1Wk | 22,83,201 |
| Low price | 451 ₹ | High price | 654 ₹ | PEG Ratio | 1.70 | Debt to equity | 0.24 |
| 52w Index | 3.27 % | Qtr Profit Var | 68.2 % | EPS | 15.2 ₹ | Industry PE | 20.8 |
📊 PATANJALI shows moderate fundamentals for long-term investment. The stock trades at a P/E of 29.6, slightly above the industry average (20.8), suggesting mild overvaluation. ROE (12.1%) and ROCE (15.6%) are decent, reflecting fair capital efficiency. Dividend yield (0.77%) adds limited income appeal. EPS is ₹15.2, and PEG ratio (1.70) indicates growth at a reasonable valuation. Debt-to-equity (0.24) is manageable. Quarterly PAT improved (₹517 Cr. → ₹624 Cr.), showing strong earnings momentum, though RSI (40.4) suggests the stock is oversold, offering potential accumulation opportunities.
💡 Ideal Entry Price Zone: Accumulation is favorable around ₹450–₹470, near the recent low (₹451) and below DMA 50 (₹482). Current price (₹457) is within this zone, making it attractive for gradual accumulation.
📈 Exit Strategy / Holding Period: For existing holders, PATANJALI is suitable for medium to long-term holding (3–5 years). Exit can be considered near ₹630–₹650 (recent high zone) if valuations stretch without earnings growth. Otherwise, continue holding for compounding benefits supported by improving profitability.
Positive
- 📈 ROCE (15.6%) and ROE (12.1%) show decent efficiency.
- 📊 PEG ratio (1.70) indicates balanced growth and valuation.
- 💸 Dividend yield (0.77%) provides modest income.
- 📉 Debt-to-equity (0.24) is manageable.
- 📈 PAT improved quarter-on-quarter (₹517 Cr. → ₹624 Cr.).
Limitation
- ⚠️ P/E (29.6) is higher than industry average (20.8).
- 📉 Dividend yield is relatively low.
- 📊 RSI (40.4) suggests oversold conditions, but volatility remains.
- 📉 Institutional confidence weakened with FII (-1.62%) and DII (-0.98%) declines.
Company Negative News
- 📉 FII holdings decreased (-1.62%), showing reduced foreign investor confidence.
- 📊 DII holdings also declined (-0.98%), reflecting weaker domestic support.
Company Positive News
- 📈 PAT growth quarter-on-quarter shows strong operational improvement.
- 📊 EPS at ₹15.2 reflects profitability.
- 📉 Debt levels remain low, ensuring financial safety.
Industry
- 🏭 FMCG/consumer goods industry PE is 20.8, lower than PATANJALI’s 29.6, suggesting mild overvaluation.
- 📊 Industry growth remains strong, driven by rising demand for health and wellness products.
Conclusion
⚖️ PATANJALI is moderately valued with decent ROE, ROCE, and improving profitability. Ideal entry is near ₹450–₹470, which aligns with current levels. Existing holders can continue for 3–5 years, with exit considered near ₹630–₹650 if earnings growth slows. Overall, PATANJALI is a fair candidate for long-term portfolios in the FMCG sector, but investors should monitor institutional sentiment and valuation risks.